Related Experiment Videos
Mosaic AZF deletions and susceptibility to testicular tumors
Néstor O Bianchi1, Silvina M Richard, Päivi Peltomäki
1Instituto Multidisciplinario de Biología Celular (IMBICE), La Plata, Argentina. bianchi@satlink.com
Abstract:
We tested for azoospermia factor (AZF) deletions 17 loci corresponding to AZF subintervals a-d in 17 cases of testicular tumors occurring in Finns. While DNA samples from 48 CEPH and 32 Finnish males showed no deletions, patients with testicular cancer displayed AZF deletion mosaicisms in various non-tumor tissues (13 cases) and specific deletion haplotypes in tumor tissues (10 cases). Two of the cases with AZF deletions were testicular non-Hodgkin lymphomas indicating that Y-microdeletions appear also in malignancies other than seminoma and non-seminoma tumors. In good agreement with this assumption, we detected one AZF deletion in normal cells from 1 of 5 HNPCC cases, heterozygous for an MLH1 mutation. We propose that AZF deletions occur in early embryogenesis due to mutations of TSPY, mismatch repair (MMR), or X-specific genes. Since fathers of testicular, tumor cases did not exhibit AZF deletions, we assumed they were not carriers of the mutation inducing AZF deletion-mosaicisms. Therefore, tumor cases should have received the MMR gene or X mutations via the maternal lineage, or for the case of TSPY and MMR genes via a sperm carrying a mutation occurred in the paternal germ-cell line. We consider AZF microdeletions in non-tumor cells to be part of a broader pattern of chromosome instability producing susceptibility to testicular tumors. Clonal transformation and expansion of one of these tumor-susceptible cell lineages give rise to testicular tumors showing genome anomalies characteristic of testicular cancers (i12p, LOH and genetic imbalance for various autosomal regions, Y- and autosomal MSI, specific AZF deletion haplotypes).
Insights
Azoospermia factor (AZF) microdeletions in non-tumor cells are linked to testicular cancer susceptibility. These deletions may arise early in development, potentially through maternal inheritance or paternal germline mutations, contributing to chromosome instability and tumor formation.
Area of Science:
- Genetics
- Oncology
- Reproductive Biology
Background:
- Azoospermia factor (AZF) deletions are associated with male infertility.
- Testicular cancer is a significant malignancy in young men.
- The genetic underpinnings of testicular cancer susceptibility are not fully understood.
Purpose of the Study:
- To investigate the presence and significance of AZF deletions in testicular tumor patients.
- To explore the potential role of AZF deletions in the development of testicular malignancies.
- To determine the inheritance patterns of AZF deletions in affected families.
Main Methods:
- Screening of 17 AZF loci for deletions in testicular tumor cases and control groups.
- Analysis of DNA from tumor and non-tumor tissues.
- Genetic analysis of familial cases to trace inheritance patterns.
Main Results:
- AZF deletion mosaicisms were found in non-tumor tissues of 13 testicular cancer patients.
- Specific AZF deletion haplotypes were detected in tumor tissues of 10 patients.
- AZF deletions were also observed in other malignancies, including non-Hodgkin lymphoma and HNPCC cases, suggesting a broader role.
Conclusions:
- AZF microdeletions in non-tumor cells may indicate a predisposition to testicular tumors due to chromosome instability.
- Deletions likely occur during early embryogenesis, possibly via maternal inheritance or paternal germline mutations.
- AZF deletions are implicated in the pathogenesis of testicular cancers, alongside other genomic anomalies.